Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Cara Therapeutics Stock Price (Quote) NASDAQ:CARA
$11.95 ( 2.58% ) Friday, 14th Jan 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $11.50 | $12.97 | Friday, 14th Jan 2022 CARA stock ended at $11.95. This is 2.58% more than the trading day before Thursday, 13th Jan 2022. During the day the stock fluctuated 3.54% from a day low at $11.58 to a day high of $11.99. |
| 90 days | $11.50 | $18.93 | |
| 52 weeks | $11.22 | $29.65 |
Historical Cara Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2022-01-14 | $11.70 | $11.99 | $11.58 | $11.95 | 307 393 |
| 2022-01-13 | $11.89 | $12.01 | $11.61 | $11.65 | 271 915 |
| 2022-01-12 | $12.33 | $12.36 | $11.91 | $11.93 | 245 507 |
| 2022-01-11 | $11.99 | $12.37 | $11.99 | $12.29 | 348 251 |
| 2022-01-10 | $11.76 | $12.16 | $11.53 | $12.13 | 498 117 |
| 2022-01-07 | $11.73 | $11.98 | $11.62 | $11.76 | 431 892 |
| 2022-01-06 | $11.70 | $11.93 | $11.50 | $11.66 | 301 800 |
| 2022-01-05 | $12.49 | $12.66 | $11.65 | $11.67 | 515 862 |
| 2022-01-04 | $12.70 | $12.97 | $12.34 | $12.48 | 356 767 |
| 2022-01-03 | $12.30 | $12.77 | $12.16 | $12.65 | 385 031 |
| 2021-12-31 | $12.34 | $12.58 | $12.16 | $12.18 | 328 501 |
| 2021-12-30 | $12.21 | $12.75 | $12.04 | $12.34 | 433 099 |
| 2021-12-29 | $12.32 | $12.40 | $12.10 | $12.21 | 349 539 |
| 2021-12-28 | $12.51 | $12.65 | $12.23 | $12.25 | 319 074 |
| 2021-12-27 | $12.68 | $12.76 | $12.46 | $12.57 | 294 558 |
| 2021-12-23 | $12.38 | $12.73 | $12.18 | $12.66 | 396 252 |
| 2021-12-22 | $12.29 | $12.48 | $12.14 | $12.27 | 312 919 |
| 2021-12-21 | $12.29 | $12.51 | $12.18 | $12.29 | 417 571 |
| 2021-12-20 | $12.38 | $12.40 | $11.95 | $12.21 | 630 868 |
| 2021-12-17 | $12.05 | $12.67 | $11.85 | $12.45 | 1 560 397 |
| 2021-12-16 | $12.48 | $12.52 | $12.05 | $12.18 | 598 021 |
| 2021-12-15 | $11.97 | $12.50 | $11.62 | $12.48 | 668 911 |
| 2021-12-14 | $12.02 | $12.17 | $11.77 | $11.99 | 425 935 |
| 2021-12-13 | $12.27 | $12.35 | $11.93 | $12.18 | 515 253 |
| 2021-12-10 | $12.52 | $12.66 | $12.07 | $12.10 | 438 065 |
| 2021-12-09 | $12.67 | $12.95 | $12.35 | $12.37 | 430 168 |
| 2021-12-08 | $12.82 | $13.03 | $12.59 | $12.80 | 317 219 |
| 2021-12-07 | $12.22 | $12.95 | $12.22 | $12.74 | 477 963 |
| 2021-12-06 | $12.31 | $12.50 | $12.04 | $12.14 | 425 602 |
| 2021-12-03 | $12.90 | $13.02 | $12.22 | $12.31 | 499 775 |
| 2021-12-02 | $12.61 | $12.91 | $12.39 | $12.89 | 704 158 |
| 2021-12-01 | $13.30 | $13.32 | $12.61 | $12.61 | 688 108 |
| 2021-11-30 | $13.00 | $13.40 | $12.70 | $13.18 | 919 732 |
| 2021-11-29 | $12.95 | $13.23 | $12.54 | $12.58 | 507 214 |
| 2021-11-26 | $13.25 | $13.30 | $12.49 | $12.80 | 510 563 |
| 2021-11-24 | $13.26 | $13.46 | $13.06 | $13.34 | 521 643 |
| 2021-11-23 | $13.58 | $13.92 | $13.24 | $13.44 | 940 034 |
| 2021-11-22 | $14.16 | $14.45 | $13.50 | $13.63 | 728 116 |
| 2021-11-19 | $14.40 | $14.72 | $14.15 | $14.18 | 636 416 |
| 2021-11-18 | $14.86 | $14.99 | $14.12 | $14.44 | 726 385 |
| 2021-11-17 | $15.20 | $15.48 | $14.78 | $14.84 | 721 755 |
| 2021-11-16 | $15.50 | $15.64 | $15.11 | $15.32 | 567 031 |
| 2021-11-15 | $16.13 | $16.28 | $15.43 | $15.64 | 537 665 |
| 2021-11-12 | $16.30 | $16.58 | $15.93 | $16.25 | 460 870 |
| 2021-11-11 | $16.93 | $17.39 | $16.16 | $16.17 | 550 381 |
| 2021-11-10 | $17.77 | $18.60 | $16.54 | $16.56 | 906 893 |
| 2021-11-09 | $17.23 | $18.93 | $17.23 | $18.14 | 1 269 486 |
| 2021-11-08 | $17.81 | $17.99 | $17.16 | $17.23 | 543 243 |
| 2021-11-05 | $17.63 | $18.28 | $17.30 | $17.89 | 711 599 |
| 2021-11-04 | $17.20 | $17.87 | $16.86 | $17.65 | 594 999 |
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system. Its lead product candidate includes I.V. CR845, which is in Phase III clinical trials for the treatment acute postop... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
